These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 24331024

  • 1. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W, Liang X, Cui F, Li L, Hadler SC, Hutin YJ, Kane M, Wang Y.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [Abstract] [Full Text] [Related]

  • 2. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA, Hadler SC, Lee L, Shapiro CN, Cui F, Wang X, Kumar R.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, Hadler SC, Hutin YJ, Liang X, Yang W.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The impact of hepatitis B vaccine in China and in the China GAVI Project.
    Hadler SC, Fuqiang C, Averhoff F, Taylor T, Fuzhen W, Li L, Xiaofeng L, Weizhong Y.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J66-72. PubMed ID: 24331023
    [Abstract] [Full Text] [Related]

  • 6. Preventing hepatitis B though universal vaccination: reduction of inequalities through the GAVI China project.
    Cui F, Liang X, Gong X, Chen Y, Wang F, Zheng H, Wu Z, Miao N, Hadler SC, Hutin YJ, Luo H, Yang W.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J29-35. PubMed ID: 24331017
    [Abstract] [Full Text] [Related]

  • 7. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 27; 11(4):203-5. PubMed ID: 12716514
    [Abstract] [Full Text] [Related]

  • 8. The China GAVI Project.
    Berkley S.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J3-4. PubMed ID: 24331018
    [No Abstract] [Full Text] [Related]

  • 9. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.
    Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W.
    Vaccine; 2010 Aug 23; 28(37):5973-8. PubMed ID: 20637773
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China].
    Cui FQ, Gong XH, Chen YS.
    Zhongguo Yi Miao He Mian Yi; 2009 Aug 23; 15(4):289-93. PubMed ID: 20077723
    [Abstract] [Full Text] [Related]

  • 11. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China.
    Li F, Wang Q, Zhang L, Su H, Zhang J, Wang T, Huang D, Wu J, Yan Y, Fan D.
    Vaccine; 2012 Nov 19; 30(49):7118-22. PubMed ID: 23022150
    [Abstract] [Full Text] [Related]

  • 12. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J, Zhang J, Wu C, Shao X, Peng G, Peng Z, Ma W, Zhang Y, Zheng H.
    Int J Infect Dis; 2012 Sep 19; 16(9):e692-6. PubMed ID: 22795176
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug 19; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 14. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
    Yang S, Yu C, Chen P, Deng M, Cao Q, Li Y, Ren J, Xu K, Yao J, Xie T, Wang C, Cui Y, Ding C, Tian G, Wang B, Zhang X, Ruan B, Li L.
    Sci Rep; 2015 Dec 14; 5():18334. PubMed ID: 26655735
    [Abstract] [Full Text] [Related]

  • 15. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Sep 28; 61():768-71. PubMed ID: 23013723
    [Abstract] [Full Text] [Related]

  • 16. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.
    Wang F, Shen L, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Wang F, Bi S.
    Vaccine; 2015 May 28; 33(23):2704-9. PubMed ID: 25843269
    [Abstract] [Full Text] [Related]

  • 17. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
    Fischer G, Wang S, Ahring S, Fowler K, Hainline S, Chinglong M, Jacques-Carroll L, Bell B, Williams I.
    Pediatr Infect Dis J; 2009 Jul 28; 28(7):593-7. PubMed ID: 19455073
    [Abstract] [Full Text] [Related]

  • 18. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 May 11; 56(18):441-5. PubMed ID: 17495790
    [Abstract] [Full Text] [Related]

  • 19. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
    Averhoff F, Kolwaite A, Ward JW.
    Vaccine; 2013 Dec 27; 31 Suppl 9():J5-7. PubMed ID: 23623862
    [No Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL, Shu ZJ, Zhou LX, Zhao YR.
    Arch Virol; 2012 May 27; 157(5):901-5. PubMed ID: 22327392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.